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Abstract
Background: Lactase non-persistence is a condition where lactase activity is decreased in the
intestinal wall after weaning. In European derived populations a single nucleotide polymorphism
(SNP) C/T-13910 residing 13.9 kb upstream from the lactase gene has been shown to define lactase
activity, and several other single nucleotide polymorphisms (G/C-14010 T/G-13915, C/G-13907 and T/C-
13913) in the same region have been identified in African and Middle East populations.
Results: The T-13910 allele most common in European populations was present in 21.8% mixed
ancestry (N = 62) individuals and it was absent in the Xhosa (N = 109) and Ghana (N = 196)
subjects. Five other substitutions were also found in the region covering the previously reported
variants in African and Middle East populations. These included the G/C-14010 variant common in
Kenyan and Tanzanian populations, which was present in 12.8% of Xhosa population and in 8.1%
of mixed ancestry subjects. Two novel substitutions (C/T-14091 and A/C-14176) and one previously
reported substitution G/A-13937 (rs4988234) were less common and present only in the Xhosa
population. One novel substitution G/A-14107 was present in the Xhosa and Ghanaian populations.
None of the other previously reported variants were identified.
Conclusion: Identification of the G/C-14010 variant in the Xhosa population, further confirms their
genetic relatedness to other nomadic populations members that belong to the Bantu linguistic
group in Tanzania and Kenya. Further studies are needed to confirm the possible relationship of
the novel substitutions to the lactase persistence trait.
Background
Lactase non-persistence is a condition where the activity
of lactase declines during childhood leading to malab-
sorption of lactose [1]. Certain DNA-variants, however,
enable individuals to never lose their lactase activity. A
single nucleotide polymorphism (SNP) C/T-13910 residing
in intron 13 of the MCM6 gene 13.9 kb upstream from the
lactase gene (LCT) has been found to correlate perfectly
with lactase activity [2-5]. Functional studies have shown
that the C/T-13910 variant acts as an enhancer [6,7] and it
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regulates the LCT gene at the transcriptional level [3,8].
This long distance regulatory region seems to be a binding
site for the Oct-1 transcription factor [9]. Recently, other
variants close to the original variant C/T-13910 in the same
enhancer region have been identified in nomadic pasto-
ralist and non-pastoralist groups from East Africa, Cam-
eroon and Middle East populations [10-12]. The G/C-14010
variant is common in East Africa. The indirect lactose tol-
erance test (LTT) has been used to show that this variant
has a significant association with the lactase persistence
trait. Other variants associated with lactase persistence in
Africa or the Middle East are T/G-13915, C/G-13907 and T/C-
13913.  Functional in vitro studies using dual-luciferase
reporter assays have shown that the mutant C-14010, G-
13907 and G-13915 alleles increase LCT promoter expression
[10]. Tissue samples from intestinal biopsies on individu-
als from the Arabian Peninsula have been used to show a
correlation between allele G-13915 and lactase activity [11].
To further investigate genetic variants in African popula-
tions we sequenced the 400 bp region covering the previ-
ously identified variants from DNA-samples of subjects
from Xhosa or mixed ancestry groups from South Africa.
As a comparison, we sequenced the same region in the
Akan people, a Western African linguistic group, which
has a long history of farming and trading, but no dairy cul-
ture.
Results
The identified single nucleotide substitutions and their
allele frequencies are shown in Table 1. We found a total
of six variants in the region covering 400 bp on both sides
of the original C/T-13910 variant. The distances between the
variants are shown in Figure 1.
Xhosa population
The most common substitution in Xhosa population was
allele C-14010 present in 12.8% of the subjects (Table 1).
All the Xhosa subjects were homozygous for the genotype
C/C-13910 and the T-13910-allele was completely absent. In
addition, one previously known G/A-13937 (rs4988234)
and three other novel substitutions C/T-14091, G/A-14107, A/
C-14176 were found (Table 1, Figure 1). None of the previ-
ously reported variants identified in African and Arab
populations (C/G-13907, T/C-13913, T/G-13915) [10-12] were
found in this study.
Mixed ancestry population
The frequency of the T-13910 allele was 21.8% and the C-
14010 allele 8.1% in the mixed ancestry population (Table
1). None of the previously reported mutations (C/G-13907,
T/C-13913, T/G-13915, G/A-13937) [10,12] or the novel substi-
tutions presented in this study were identified.
Akan population in Ghana
Both T-13910 and C-14010 alleles were absent in the Ghana-
ian population. Only one of the novel substitutions found
in the Xhosa population, (G/A-14107) in a heterozygous
form, was present in (the non-malaria group from) the
Ashanti Region in Ghana. None of the other novel substi-
tutions or the previously reported mutations (C/G-13907,
T/C-13913, T/G-13915, G/A-13937) [10,12] were present in this
study population.
Discussion
In Europe the C/T-13910 variant determinates lactase activ-
ity in lactase persistence/non-persistence. In pastoralist
populations of Africa several other SNPs in the same
region upstream of LCT have been identified. Functional
evidence for lactase persistence has been obtained for
some of these variants [10,12]. We analyzed the distribu-
tion of substitutions near C/T-13910 in a South African pop-
ulation that consumes milk products and compared it to
substitutions found in the Akan peoples from Ghana,
who does not have a dairy culture.
Modern humans have lived in South Africa for at least
77,000 years [13]. The early settlers of South Africa, the
KhoiKhoi and San people (collectively called the
Khoisan), were stone-age hunter-gatherers. They are often
thought to represent distinct ethnic groups [14]. Bantu
speaking people started to migrate south 2000 years ago
bringing with them smelting technology (the iron-age)
and expertise in farming [14-16]. Among the Bantu peo-
ple who migrated to Southern Africa were the Nguni who
included the Xhosas, Zulus and Ndebeles. The Xhosa and
Locations of single nucleotide substitutions found in the study Figure 1
Locations of single nucleotide substitutions found in the study. Variants previously associated with lactase activity are 
shown in bold. Substitutions are located upstream of the LCT gene. The numbers show the distance in nucleotides between 
the variant and the beginning of the LCT gene (marked as 0).
A/C-14176 G/A-14107 C/T-14091 G/A-13937 0 G/C-14010 C/T-13910 LCTBMC Genetics 2009, 10:31 http://www.biomedcentral.com/1471-2156/10/31
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Zulu people comprise a large proportion of modern day
Black South Africans. Xhosa speaking people include
many subgroups with related but distinct ancestries [17].
Most of the Xhosa-speaking peoples in today's South
Africa, originally came from the Eastern Cape province.
They consume fermented milk from the many cattle they
keep. This is generally true for most of the Bantu-speaking
populations and to some extent indicates their ability to
tolerate lactose. We did not find the C/T-13910 variant com-
mon in populations of European origin, further confirm-
ing previously reported findings that this SNP is rare in
African populations [10,12,18]. The results of our study
show that in the Xhosa population the C-14010-allele of the
polymorphic site G/C-14010 is the most common of those
alleles previously associated with lactase activity. The C-
14010 allele has also been found to be present in Tanzania
with a higher prevalence (31.9%) than in the South Afri-
can Xhosa population [10]. Because of the frequency dif-
ference and the fact that the Xhosa population originated
from Central Africa and migrated slowly southwards, we
hypothesize that the lactase persistence allele has
migrated with them and gradually diluted the frequency
of C-14010  by intermarriages with the Khoisan people
[15,16,19].
Interestingly, this study revealed three novel substitutions
C/T-14091, G/A-14107, A/C-14176 in the Xhosa population.
The substitutions are not reported in the SNP-database
http://www.ncbi.nlm.nih.gov/sites/entrez. The frequen-
cies of the substitutions are low and unlike the previously
detected T/G-13915, T/C-13913 and C/G-13907 they are not
located close to the C/T-13910 variant in the Oct-1 tran-
scription factor binding site. However, the size of
enhancer sites can be in excess of several hundred base-
pairs and it is therefore possible that all these variants are
included in the same enhancer region [20]. In order to
investigate their functional role in the regulation of lactase
activity, subjects carrying these mutations need to be
recruited and to investigate any associations between
them and the results of their lactose tolerance test (LTT) or
preferably the lactase activity of their intestinal biopsy
specimens. It is known that when the Xhosa people
migrated south, they assimilated with the earlier inhabit-
ants of Southern Africa, the Khoisan, thus, it would be
interesting to investigate the distribution of these novel
substitutions in these populations. However, as they are
rare, a large number of samples would be required in
order to uncover any functional significance for the three
novel substitutions from association studies. Another pos-
sibility is that these variants are not associated with lactase
persistence but represent the natural diversity of African
populations.
Among the people of mixed ancestry origin both the T-
13910  and the C-14010  allele were found reflecting the
genetic influence of both Africans and Europeans in this
group. This is explained by the diverse ethnic origin (Afri-
cans, Western Europeans, the Khoisan, Indonesians and
Malaysians) of these people. Therefore the results of the
mixed ancestry population group support their ethnic
background.
The Akan in the rural Ashanti region live mainly on sub-
sistence agriculture and rarely keep milk producing live-
stock. Their consumption of fresh milk products has thus
remained very limited. This explains why there has not
been any evolutionary pressure towards an increasing fre-
quency of lactose persistence genotypes, although these
genotypes are known to be present in the population.
Conclusion
Identification of the G/C-14010 variant in the Xhosa popu-
lation, further confirms their genetic relatedness to other
nomadic populations members that belong to the Bantu
linguistic group in Tanzania and Kenya. Further studies
are needed to confirm the possible relationship of the
novel substitutions to the lactase persistence trait.
Methods
Study population
The study material consisted of 171 samples collected
from Southern Africa for the study of genetic risk factors
affecting esophageal cancer [21]. Of these 109 were Xhosa
and 62 of mixed ancestry. The Black Xhosa-speaking
South Africans originated from the Eastern or Western
Capes. The mixed ancestry (commonly referred to as "col-
oured") subjects are the result of intermarriages between
Table 1: Allele frequencies of single nucleotide substitutions found in this study.
Origin N -13910*T -13937*A -14010*C -14091*T -14107*A -14176*C
Xhosa 109 0.000 0.014 0.133 0.014 0.005 0.009
Mixed Ancestry 62 0.218 0.000 0.065 0.000 0.000 0.000
Ghana 196 0.000 0.000 0.000 0.000 0.003 0.000
N = number of subjectsBMC Genetics 2009, 10:31 http://www.biomedcentral.com/1471-2156/10/31
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races including Black Africans, Western Europeans, the
Khoisan, Indonesians and Malaysians who settled in the
Cape from the middle of the 17th century. Written consent
was obtained before subjects were enrolled in the study. A
questionnaire gathering details on demographics (age,
sex, and race), smoking habits and alcohol consumption
was completed for all subjects by a trained phlebotomist.
Blood was collected from participating subjects and proc-
essed for DNA isolation [21]. The study was approved by
Cape Town University's Human Research Ethics Commit-
tee.
A total of 196 subjects were analyzed from Ghana. Diag-
nostic procedures and the malariological indices of the
women have been described elsewhere [22]. DNA was
extracted from the subjects' peripheral venous blood
(QIAmp, Qiagen). All the participants gave their informed
consent. The study protocol was reviewed and approved
by the Committee on Human Research Publication and
Ethics, School of Medical Sciences, University for Science
and Technology, Kumasi, Ghana, and the institution's
guidelines were followed in conducting the study.
Genotyping
The DNA fragment spanning the C/T-13910 variant was
amplified by polymerase chain reaction (PCR) and then
sequenced. The primer sequences used were: 5'-CCTCGT-
TAATACCCACTGACCTA-3' (forward) and 5'-GTCACTTT-
GATATGATGAGAGCA-3' (reverse). The PCR products
were separated on a 1.5% agarose gel containing ethidium
bromide for size verification. The excess primers were
removed by digestion with 2.5 U of Shrimp Alkaline
Phosphatase (USB) and 5 U of Exonuclease I (New Eng-
land Biolabs) at 37°C for 45 min followed by inactivation
at 80°C for 15 min. For sequencing the BigDye 3.1 termi-
nator (Applied Biosystems) was used according to the
manufacturer's instructions. The sequencing reaction was
as follows: at 96°C for 1 min, then 25 cycles at 96°C for
10 s, at 55°C for 5 s and at 60°C for 4 min, which was fol-
lowed by purification with Millipore Multiscreen plates
(Millipore, USA) with Sephadex G-50 Superfine sepha-
rose (Amersham Biosciences, Sweden), electrophoresis
with an ABI 3730 DNA Analyzer (Applied Biosystems)
and base calling using the Sequence Analysis 5.2 software
(Applied Biosystems). The results were analyzed by
Sequencher 4.1.4 software (Gene Codes, USA).
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